Agency Information Collection Activities: Proposed Collection; Comment Request, 307-308 [E8-31299]

Download as PDF Federal Register / Vol. 74, No. 2 / Monday, January 5, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of R03 and R21 applications. Date: January 28, 2009. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jonathan Horsford, Ph.D., Scientific Review Officer, Natl Inst of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Blvd, Room 664, Bethesda, MD 20892, 301–594–4859, horsforj@mail.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of RFA–DE–08–009 Developing Complex Models of Oral Health Behavior. Date: February 11, 2009. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Marilyn Moore-Hoon, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Dental and Craniofacial Research. 6701 Democracy Blvd., Rm. 676, Bethesda, MD 20892–4878, 301–594–4861, mooremar@nidcr.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; NIDCR Special Emphasis Panel Review of RFA DE–09–001 and RFA DE–09–002 R01 and R21 Applications. Date: February 17, 2009. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel, 8120 Wisconsin Ave., Bethesda, MD 20814. VerDate Aug<31>2005 14:05 Jan 02, 2009 Jkt 217001 307 Contact Person: Rebecca Wagenaar Miller, Ph.D., Scientific Review Officer, Scientific Review Branch, National Inst of Dental & Craniofacial Research, National Institutes of Health, 6701 Democracy Blvd., Rm 666, Bethesda, MD 20892, 301–594–0652, rwagenaa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: December 24, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–31378 Filed 1–2–09; 8:45 am] Dated: December 24, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–31376 Filed 1–2–09; 8:45 am] Substance Abuse and Mental Health Services Administration BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Biofilm P01. Date: January 12, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Tracy A. Shahan, PhD, MBA, Scientific Review Officer, Scientific Review Program, NIH/NIAID/DHHS, Room 3121, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–451–2606, tshahan@niaid.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: 2009 National Survey on Drug Use and Health Methods Field Test—NEW The National Survey on Drug Use and Health (NSDUH), formerly the National Household Survey on Drug Abuse (NHSDA) is a survey of the civilian, non-institutionalized population of the United States 12 years old and older. The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, ONDCP, Federal Government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources. The procedures and materials are currently being redesigned for the 2012 E:\FR\FM\05JAN1.SGM 05JAN1 308 Federal Register / Vol. 74, No. 2 / Monday, January 5, 2009 / Notices survey. In order to adequately test the proposed materials and procedures, a stand-alone field test will be conducted in the third quarter of 2009. This field test will examine the impact of changing a number of data collection procedures upon costs and data quality. The field test will feature an experiment assessing the benefits of offering a $5 incentive for the screening interview versus conducting the screening over the telephone. The portion of the sample that will receive the incentive will be notified of the cash payment in the lead letter. For the telephone screening sample, normal procedures will be used for the first 8 weeks. During week 8, the remaining households who have not been screened will either be contacted using a reverse look-up procedure and asked to complete the screener, or mailed a letter asking them to call a toll-free number to be screened. Other changes included in the field test version of the survey are an No. of responses increased interview incentive and a brief appeal for honesty at the beginning of the questionnaire. New respondent debriefing questions will be added to the questionnaire while debriefing items that the interviewer answers will be modified. In addition, the hard copy pill cards and reference date calendar used during the administration of the interview have been converted to an electronic format. The total burden estimate is shown below: Average burden per response (hr.) Responses per respondent Total burden (hrs.) Household Screening ...................................................................... Interview ........................................................................................... Screening Verification ...................................................................... Interview Verification ........................................................................ 3,900 1,875 390 188 1 1 1 1 .083 1.0 .067 .067 323.7 1,875 26.1 12.6 Total .......................................................................................... 6,353 ............................ ............................ 2,237 Send comments to Summer King, SAMHSA Reports Clearance Officer, Room 7–1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her a copy at summer.king@samhsa.hhs.gov. Written comments should be received within 60 days of this notice. Dated: December 24, 2008. Dennis O. Romero, Acting Deputy Executive Officer. [FR Doc. E8–31299 Filed 1–2–09; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: National Outcome Measures for Substance Abuse Prevention (OMB No. 0930–0230)—Revision The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) is requesting Office of Management and Budget (OMB) approval for CSAP’s data collection set of National Outcome Measures (NOMs) VerDate Aug<31>2005 14:05 Jan 02, 2009 Jkt 217001 identified for the field of prevention. The current approval, under OMB No. 0930–0230, is expiring on December 31, 2008. All new grantees initially funded at the end of FY08 and beyond (subject to OMB approval) will be required to use these measures as appropriate at the State, substate, program and participant levels. CSAP is requesting approval to continue collecting data using measures in the following domains: Abstinence from Alcohol and Other Drugs, Employment/Education, Crime and Criminal Justice, Access/Service Capacity, Retention, Social Support/ Social Connectedness, CostEffectiveness, and Use of EvidenceBased Practices. These NOMs relate to youth ages 12 to 17 and to adults ages 18 and older. CSAP is proposing to eliminate 22 of the 49 measures that received OMB clearance in 2005, to reduce reporting burden for grantees. CSAP also requests permission to make minor changes to the question wording and response categories for some of the remaining measures. Since the National Survey of Drug Use and Health (NSDUH) provides an economical extant source of data for NOMs measures at the State level, it is important that the NOMs conform to NSDUH question wording. CSAP believes NOMs measures are necessary to assess the performance of its prevention programs. Based on their long history working with States, communities, and prevention providers; the Data Analysis Coordination and Consolidation Center (DACCC) and outside expert panels believe consistent prevention measures allow for valid comparison evaluations. CSAP is PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 requesting to modify the wording of 12 previously approved questions in order to make them comparable to individual NOMs items. For example, NSDUH items on 30-day use ask respondents to report the number of days on which they used specific substances. Three currently approved NOMs 30-day use questions ask respondents for the number of occasions on which they used substances. CSAP would like to change the wording of these questions and their corresponding response options to conform to NSDUH wording. Second, response options for NSDUH questions typically include a Don’t Know response option. CSAP is requesting modification of nine currently approved NOMs questions to include this response option. CSAP intends to implement the following approach in collecting NOMs data: Required NOMs Data for States. CSAP pre-populates State level NOMs measures for all but three domains using data from the NSDUH. States supply the data on the number of persons served, cost efficiency, and evidence based practices from their own administrative data bases. Required NOMs Data for Discretionary Grantees. SAMHSA’s CSAP has identified specific outcome measures that are required of non-State discretionary grant recipients. These NOMs represent the domains noted above and relate to youth ages 12 to 17 and to adults ages 18 and older. Grantees providing services are required to administer surveys to all participants at program entry (baseline), program E:\FR\FM\05JAN1.SGM 05JAN1

Agencies

[Federal Register Volume 74, Number 2 (Monday, January 5, 2009)]
[Notices]
[Pages 307-308]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-31299]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer on (240) 276-1243.
    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: 2009 National Survey on Drug Use and Health Methods 
Field Test--NEW

    The National Survey on Drug Use and Health (NSDUH), formerly the 
National Household Survey on Drug Abuse (NHSDA) is a survey of the 
civilian, non-institutionalized population of the United States 12 
years old and older. The data are used to determine the prevalence of 
use of tobacco products, alcohol, illicit substances, and illicit use 
of prescription drugs. The results are used by SAMHSA, ONDCP, Federal 
Government agencies, and other organizations and researchers to 
establish policy, direct program activities, and better allocate 
resources. The procedures and materials are currently being redesigned 
for the 2012

[[Page 308]]

survey. In order to adequately test the proposed materials and 
procedures, a stand-alone field test will be conducted in the third 
quarter of 2009. This field test will examine the impact of changing a 
number of data collection procedures upon costs and data quality.
    The field test will feature an experiment assessing the benefits of 
offering a $5 incentive for the screening interview versus conducting 
the screening over the telephone. The portion of the sample that will 
receive the incentive will be notified of the cash payment in the lead 
letter. For the telephone screening sample, normal procedures will be 
used for the first 8 weeks. During week 8, the remaining households who 
have not been screened will either be contacted using a reverse look-up 
procedure and asked to complete the screener, or mailed a letter asking 
them to call a toll-free number to be screened.
    Other changes included in the field test version of the survey are 
an increased interview incentive and a brief appeal for honesty at the 
beginning of the questionnaire. New respondent debriefing questions 
will be added to the questionnaire while debriefing items that the 
interviewer answers will be modified. In addition, the hard copy pill 
cards and reference date calendar used during the administration of the 
interview have been converted to an electronic format.
    The total burden estimate is shown below:

----------------------------------------------------------------------------------------------------------------
                                                                               Average burden
                                          No. of responses    Responses per     per response      Total burden
                                                               respondent           (hr.)            (hrs.)
----------------------------------------------------------------------------------------------------------------
Household Screening.....................             3,900                 1              .083             323.7
Interview...............................             1,875                 1               1.0             1,875
Screening Verification..................               390                 1              .067              26.1
Interview Verification..................               188                 1              .067              12.6
                                         -----------------------------------------------------------------------
    Total...............................             6,353  ................  ................             2,237
----------------------------------------------------------------------------------------------------------------

    Send comments to Summer King, SAMHSA Reports Clearance Officer, 
Room 7-1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her 
a copy at summer.king@samhsa.hhs.gov. Written comments should be 
received within 60 days of this notice.

    Dated: December 24, 2008.
Dennis O. Romero,
Acting Deputy Executive Officer.
[FR Doc. E8-31299 Filed 1-2-09; 8:45 am]
BILLING CODE 4162-20-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.